Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim-supported intensified consolidation therapy in older patients with acute myeloid leukemia
2007-005806-29Phase 4Terminated
- Sponsor
- Medical University of Vienna
- Start
- Apr 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pegfilgrastim in acute myeloid leukemia (AML), sponsored by Medical University of Vienna. Primary endpoints: Number of chemotherapy cycles received, Dropout rate and 1 more. Started Apr 2008; status: terminated.
02
Drugs
pegfilgrastim
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on 2007-005806-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005806-29.